| AR expression |  | |||||||
---|---|---|---|---|---|---|---|---|---|
 | Absent | Poor | Moderate | High |  | ||||
 | No. | %b | No. | %b | No. | %b | No. | %b | P c |
Age, yr | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 < 65 | 29 | 49.2 | 55 | 49.1 | 57 | 47.5 | 68 | 42.5 | 0.259 |
 ≥ 65 | 30 | 50.8 | 57 | 50.9 | 63 | 52.5 | 92 | 57.5 | |
BMI, kg/m2 | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 < 25 | 28 | 50.0 | 45 | 46.9 | 58 | 52.7 | 68 | 47.2 | 0.478 |
 25-30 | 18 | 32.1 | 41 | 42.7 | 34 | 30.9 | 44 | 30.6 | |
 ≥ 30 | 10 | 17.9 | 10 | 10.4 | 18 | 16.4 | 32 | 22.2 | |
Tumor size, cm | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 < 2 | 32 | 55.2 | 74 | 66.7 | 70 | 58.8 | 112 | 70.9 | 0.080 |
 ≥ 2 | 26 | 44.8 | 37 | 33.3 | 49 | 41.2 | 46 | 29.1 | |
Histology | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Infiltrating ductal carcinoma (IDC) | 50 | 89.3 | 87 | 79.8 | 95 | 80.5 | 124 | 77.5 | 0.110 |
 Other infiltrating carcinoma | 6 | 10.7 | 22 | 20.2 | 23 | 19.5 | 36 | 22.5 | |
Grade | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 ≤ 2 | 22 | 37.9 | 68 | 61.3 | 72 | 61.5 | 112 | 70.4 | <0.001 |
 > 2 | 36 | 62.1 | 43 | 38.7 | 45 | 38.5 | 47 | 29.6 | |
Axillary nodal status | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Negative | 34 | 60.7 | 66 | 60.6 | 74 | 62.7 | 95 | 60.1 | 0.958 |
 Positive | 22 | 39.3 | 43 | 39.4 | 44 | 37.3 | 63 | 39.9 | |
ER status | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Negative | 28 | 47.5 | 20 | 18.0 | 13 | 10.8 | 10 | 6.3 | <0.001 |
 Positive | 31 | 52.5 | 91 | 82.0 | 107 | 89.2 | 149 | 93.7 | |
PR status | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Negative | 34 | 57.6 | 42 | 38.2 | 37 | 30.8 | 36 | 22.6 | <0.001 |
 Positive | 25 | 42.4 | 68 | 61.8 | 83 | 69.2 | 123 | 77.4 | |
HER2 statusa | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Negative | 30 | 58.8 | 35 | 41.7 | 40 | 48.2 | 64 | 59.3 | 0.332 |
 Positive | 21 | 41.2 | 49 | 58.3 | 43 | 51.8 | 44 | 40.7 | |
Total | 59 | 13.1 d | 112 | 24.8 d | 120 | 26.6 d | 160 | 35.5 d | Â |